127 related articles for article (PubMed ID: 28288880)
1. Dual-agonist occupancy of orexin receptor 1 and cholecystokinin A receptor heterodimers decreases G-protein-dependent signaling and migration in the human colon cancer cell line HT-29.
Bai B; Chen X; Zhang R; Wang X; Jiang Y; Li D; Wang Z; Chen J
Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1153-1164. PubMed ID: 28288880
[TBL] [Abstract][Full Text] [Related]
2. Heterodimerization of human orexin receptor 1 and kappa opioid receptor promotes protein kinase A/cAMP-response element binding protein signaling via a Gαs-mediated mechanism.
Chen J; Zhang R; Chen X; Wang C; Cai X; Liu H; Jiang Y; Liu C; Bai B
Cell Signal; 2015 Jul; 27(7):1426-38. PubMed ID: 25866368
[TBL] [Abstract][Full Text] [Related]
3. Transmembrane peptide 4 and 5 of APJ are essential for its heterodimerization with OX1R.
Wan L; Xu F; Liu C; Ji B; Zhang R; Wang P; Wu F; Pan Y; Yang C; Wang C; Chen J
Biochem Biophys Res Commun; 2020 Jan; 521(2):408-413. PubMed ID: 31668922
[TBL] [Abstract][Full Text] [Related]
4. The orexin 1 receptor modulates kappa opioid receptor function via a JNK-dependent mechanism.
Robinson JD; McDonald PH
Cell Signal; 2015 Jul; 27(7):1449-56. PubMed ID: 25857454
[TBL] [Abstract][Full Text] [Related]
5. Disruption of 5-hydroxytryptamine 1A receptor and orexin receptor 1 heterodimer formation affects novel G protein-dependent signaling pathways and has antidepressant effects in vivo.
Zhang R; Li D; Mao H; Wei X; Xu M; Zhang S; Jiang Y; Wang C; Xin Q; Chen X; Li G; Ji B; Yan M; Cai X; Dong B; Randeva HS; Liu C; Chen J
Transl Psychiatry; 2022 Mar; 12(1):122. PubMed ID: 35338110
[TBL] [Abstract][Full Text] [Related]
6. Heterodimerization of mouse orexin type 2 receptor variants and the effects on signal transduction.
Wang C; Pan Y; Zhang R; Bai B; Chen J; Randeva HS
Biochim Biophys Acta; 2014 Mar; 1843(3):652-63. PubMed ID: 24368186
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin Through GHSR1a and OX1R Heterodimers Reveals a Gαs-cAMP-cAMP Response Element Binding Protein Signaling Pathway
Xue Q; Bai B; Ji B; Chen X; Wang C; Wang P; Yang C; Zhang R; Jiang Y; Pan Y; Cheng B; Chen J
Front Mol Neurosci; 2018; 11():245. PubMed ID: 30065627
[TBL] [Abstract][Full Text] [Related]
8. Orexin-corticotropin-releasing factor receptor heteromers in the ventral tegmental area as targets for cocaine.
Navarro G; Quiroz C; Moreno-Delgado D; Sierakowiak A; McDowell K; Moreno E; Rea W; Cai NS; Aguinaga D; Howell LA; Hausch F; Cortés A; Mallol J; Casadó V; Lluís C; Canela EI; Ferré S; McCormick PJ
J Neurosci; 2015 Apr; 35(17):6639-53. PubMed ID: 25926444
[TBL] [Abstract][Full Text] [Related]
9. Biased signaling at chemokine receptors.
Corbisier J; Galès C; Huszagh A; Parmentier M; Springael JY
J Biol Chem; 2015 Apr; 290(15):9542-54. PubMed ID: 25614627
[TBL] [Abstract][Full Text] [Related]
10. Modulation of G-protein-coupled receptor 55-mediated signaling by regulator of G-protein signaling 2.
Jang H; Kim Y; Ghil S
Biochem Biophys Res Commun; 2020 Dec; 533(4):1233-1239. PubMed ID: 33092790
[TBL] [Abstract][Full Text] [Related]
11. Human orexin/hypocretin receptors form constitutive homo- and heteromeric complexes with each other and with human CB1 cannabinoid receptors.
Jäntti MH; Mandrika I; Kukkonen JP
Biochem Biophys Res Commun; 2014 Mar; 445(2):486-90. PubMed ID: 24530395
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of amphetamine over the corticotropin-releasing factor CRF
Navarro G; Medrano M; Aguinaga D; Vega-Quiroga I; Lillo A; Jiménez J; Casanovas M; Canela EI; Mallol J; Gysling K; Franco R
Neuropharmacology; 2019 Jul; 152():102-111. PubMed ID: 30465812
[TBL] [Abstract][Full Text] [Related]
13. Effect of orexin A on apoptosis in BGC-823 gastric cancer cells via OX1R through the AKT signaling pathway.
Wen J; Zhao Y; Shen Y; Guo L
Mol Med Rep; 2015 May; 11(5):3439-44. PubMed ID: 25586545
[TBL] [Abstract][Full Text] [Related]
14. A hallmark of immunoreceptor, the tyrosine-based inhibitory motif ITIM, is present in the G protein-coupled receptor OX1R for orexins and drives apoptosis: a novel mechanism.
Voisin T; El Firar A; Rouyer-Fessard C; Gratio V; Laburthe M
FASEB J; 2008 Jun; 22(6):1993-2002. PubMed ID: 18198212
[TBL] [Abstract][Full Text] [Related]
15. Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders.
Xu TR; Yang Y; Ward R; Gao L; Liu Y
Cell Signal; 2013 Dec; 25(12):2413-23. PubMed ID: 23917208
[TBL] [Abstract][Full Text] [Related]
16. GPCR-Gα protein precoupling: Interaction between Ste2p, a yeast GPCR, and Gpa1p, its Gα protein, is formed before ligand binding via the Ste2p C-terminal domain and the Gpa1p N-terminal domain.
Cevheroğlu O; Becker JM; Son ÇD
Biochim Biophys Acta Biomembr; 2017 Dec; 1859(12):2435-2446. PubMed ID: 28958779
[TBL] [Abstract][Full Text] [Related]
17. Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?
Hoyer D; Jacobson LH
Neuropeptides; 2013 Dec; 47(6):477-88. PubMed ID: 24215799
[TBL] [Abstract][Full Text] [Related]
18. The chemokine CXC4 and CC2 receptors form homo- and heterooligomers that can engage their signaling G-protein effectors and βarrestin.
Armando S; Quoyer J; Lukashova V; Maiga A; Percherancier Y; Heveker N; Pin JP; Prézeau L; Bouvier M
FASEB J; 2014 Oct; 28(10):4509-23. PubMed ID: 25053617
[TBL] [Abstract][Full Text] [Related]
19. Regions of MRAP2 required for the inhibition of orexin and prokineticin receptor signaling.
Rouault AAJ; Lee AA; Sebag JA
Biochim Biophys Acta Mol Cell Res; 2017 Dec; 1864(12):2322-2329. PubMed ID: 28939058
[TBL] [Abstract][Full Text] [Related]
20. Novel signaling of dynorphin at κ-opioid receptor/bradykinin B2 receptor heterodimers.
Ji B; Liu H; Zhang R; Jiang Y; Wang C; Li S; Chen J; Bai B
Cell Signal; 2017 Feb; 31():66-78. PubMed ID: 28069442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
